ArticlePediatric nephrology (Berlin, Germany)2026
Safety and efficacy of low-dose initial citrate infusion for continuous kidney replacement therapy in critically ill children.
Article in Pediatric nephrology (Berlin, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCircuit survival (CS) is critical for the maintenance of continuous kidney replacement therapy (CKRT). Regional citrate anticoagulation (RCA) is widely used, effective, and relatively safe; however, it is associated with complications such as citrate accumulation (CA). We aimed to analyze how a lower citrate infusion dose (CID) protocol could impact CS and risks for CA.
methodsThis retrospective single-center cohort study compared the efficacy and safety of standard CID (3.0 mmol/L) and low CID (2.2-2.5 mmol/L) at initial administration in patients receiving RCA for CKRT in a pediatric intensive care unit.
resultsA total of 127 patients received 239 circuits (115 circuits in 55 recipients of standard CID, and 124 filters in 72 recipients of low CID). When filter life was limited to 72 h, median CS for all filters was similar between the standard and low CID groups (51.0 h [IQR: 25.0-72.0] vs. 49.5 h [IQR: 24.0-72.0]; p = 0.857). CS was also similar in circuits terminated due to clotting (standard CID: 38.0 h [IQR: 20.0-58.0], low CID: 37.5 h [IQR: 18.0-55.0]). Recipients of the low CID protocol had significantly lower frequencies of metabolic alkalosis, CA, and hypocalcemia. Multivariate regression identified two independent CA risk factors: longer circuit runtime (OR 1.013, 95% CI 1.002-1.025) and higher weight-adjusted blood flow rates (OR 1.208, 95% CI 1.022-1.427).
conclusionsAdministering a low CID when initializing RCA significantly reduces the likelihood of citrate-related complications while maintaining anticoagulant efficacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.